EMA starts rolling review for Moderna's COVID-19 vaccine candidate

Nov 16 (Reuters) - Europe’s health regulator said on Monday it had started a real-time review of Moderna Inc’s experimental vaccine for COVID-19, on the back of similar such review launches for vaccines from AstraZeneca and Pfizer .

The European Medicines Agency’s human medicines committee has started a “rolling review” for Moderna’s mRNA-1273 vaccine candidate and has already started evaluating the first batch of data, the regulator said. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Sriraj Kalluvila)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.